reports
S&P reviews Banco Inter's outlook to Stable and reaffirms its "brAA+" ...
S&P reviews Banco Inter's outlook to Stable and reaffirms its "brAA+" rating BELO HORIZONTE, Brazil, May 20, 2024 (GLOBE NEWSWIRE) -- Inter&Co (NASDAQ: INTR), the financial super app serving over 32 million customers across the Americas, announced today that S&P Global Ratings (S&P) has upgraded Banco Inter outlook to "Stable" and reaffirmed its "brAA+" local rating. In the report S&P stated that: "The stable outlook reflects our view that Inter&Co will continue to improve its profitability, providing greater stability to the business." The outlook review was based on several factors su...
Moody's Ratings revises University Corporation for Atmospheric Researc...
Moody's Ratings (Moody's) has revised the University Corporation for Atmospheric Research's (UCAR; CO) outlook to positive from stable and affirmed its A2 revenue bond rating. UCAR's revenue bonds were issued through the Colorado Educational and Cultural Facilities Authority. At fiscal end September...
Moody's Ratings assigns rating to one class of CLO refinancing notes i...
Moody's Ratings (Moody's) has assigned a rating to one class of CLO refinancing notes (the "Refinancing Notes") issued by Trestles CLO II, Ltd. (the "Issuer"). Moody's rating action is as follows: U.S.$248,000,000 Class A-1-R Senior Secured Floating Rate Notes due 2037, Assigned Aaa (sf) RATIN...
Barclays Bank PLC Increases Purchase Price of Certain Cash Tender Offe...
NEW YORK--(BUSINESS WIRE)-- Barclays Bank PLC (the “Issuer”) announced today that, in connection with its previously announced cash tender offers (each, an “Offer”) to purchase any and all of its outstanding exchange-traded notes (the “Notes” or the “ETNs”) of thirteen separate series (each, a “Series”) and the solicitation of consents (each, a “Consent Solicitation”) from holders of the Notes (the “Noteholders”) to amend certain provisions of the Notes with respect to each Series, it has increased the Purchase Price per Note applicable to certain Series. Each Offer and Consent Solicitation ...
Moody's Ratings affirms Epicor's B2 CFR; assigns B2 rating to new cred...
Moody's Ratings (Moody's) affirmed Epicor Software Corporation (CD&R)'s (Epicor) B2 Corporate Family Rating (CFR) and B2-PD Probability of Default Rating (PDR). In addition, Moody's assigned a B2 rating to the new $270 million senior secured first lien revolver due 2029 (New Revolver), $325 million ...
Moody's Ratings downgrades Nutley School District, NJ to A2 from Aa3
Moody's Ratings (Moody's) has downgraded Nutley School District, NJ's issuer and GOULT ratings to A2 from Aa3. The district had approximately $30.4 million in debt outstanding as of June 30, 2023. The downgrade of the ratings to A2 from Aa3 reflects the substantial weakening of the district's fina...
Targa Resources Corp. to Participate in 21st Annual Energy Infrastruct...
Targa Resources Corp. to Participate in 21st Annual Energy Infrastructure CEO & Investor Conference HOUSTON, May 20, 2024 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that representatives from the Company will participate in investor meetings at the 21st Annual Energy Infrastructure CEO & Investor Conference in Aventura, FL on Wednesday, May 22, 2024. A copy of the slides used for the conference meetings will be available in the Investors section of the Company's website at , or by going to . About Targa Resources Corp. Targa Resourc...
The ODP Corporation to Participate in the B. Riley Securities Institut...
BOCA RATON, Fla.--(BUSINESS WIRE)-- The ODP Corporation (“ODP,” or the “Company”) (NASDAQ:ODP), a leading provider of business services, products and digital workplace technology solutions to businesses and consumers, announced today that its executive vice president and chief financial officer, D. Anthony Scaglione, and vice president of investor relations and treasurer, Tim Perrott, will participate in the B. Riley Securities Institutional Investor Conference on May 22nd, 2024. About The ODP Corporation The ODP Corporation (NASDAQ:ODP) is a leading provider of products and services through...
Moody's Ratings downgrades Therapy Brands' CFR to Caa1 on negative fre...
Moody's Ratings (Moody's) downgraded Therapy Brands Holdings LLC's (Therapy Brands) Corporate Family Rating (CFR) to Caa1 from B3 and Probability of Default Rating (PDR) to Caa1-PD from B3-PD. Concurrently, Moody's downgraded the company's senior secured first lien bank credit facilities ratings, wh...
Raymond James Financial Declares Quarterly Dividends on Common and Pre...
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock ST. PETERSBURG, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- On May 20, 2024, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.45 per share, payable July 15, 2024 to shareholders of record on July 1, 2024. The Board declared a quarterly dividend of $0.3984375 per depositary share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (NYSE: RJF PrB) payable July 1, 2024, to shareholders of recor...
IDEX Biometrics – Number of shares in Tranche 1 vs Tranche 2 in the pr...
IDEX Biometrics – Number of shares in Tranche 1 vs Tranche 2 in the private placement on 15 May 2024 Reference is made to the stock exchange announcement by IDEX Biometrics ASA (the “Company”) on 15 May 2024 regarding a successful private placement of shares. By inadvertence, the announcement contained a slight error in the allocation of private placement shares between Tranche 1, as issued by the Board pursuant to an authorization to issue shares granted by the extraordinary general meeting dated 21 December 2023, and Tranche 2, to be issued subject to approval by an extraordinary genera...
Moody's Ratings: No adverse rating impact on Atlanta, GA Water and Was...
Moody's Ratings (Moody's) announced today that the proposed amendment to the debt service reserve requirement for the City of Atlanta, GA Water and Wastewater Enterprise's senior lien revenue bonds would not, in and of itself and as of this point in time, result in a reduction, placement on review f...
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides C...
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates MIAMI, May 20, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today reported financial results for the first quarter ended March 31, 2024, and provided a company update. “As we work towards upcoming SAB-142 milestones, I remain enthusiastic about our ongoing pro...
Moody's Ratings assigns ratings to three classes of CLO refinancing no...
Moody's Ratings (Moody's) has assigned ratings to three classes of CLO refinancing notes (the "Refinancing Notes") issued by Regatta XV Funding Ltd. (the "Issuer"). Moody's rating action is as follows: U.S.$333,491,141 Class A-1-R Senior Secured Floating Rate Notes Due 2031 (the "Class A-1-R Not...
Xcel Brands, Inc. Announces First Quarter 2024 Results
Xcel Brands, Inc. Announces First Quarter 2024 Results Net Licensing Revenues flat year-over-year at $2.2 million for the quarter.Direct Operating Costs and Expenses of $4.0 million for the quarter, a reduction of $3.0 million or 43% from the prior year quarter.GAAP net loss of $6.3 million for the quarter, compared with GAAP net loss of $6.0 million in the prior year quarter.Adjusted EBITDA of ($1.6) million for the quarter, compared with Adjusted EBITDA of ($3.0) million for the prior year quarter, an improvement of $1.4 million. NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Xcel Brands, ...
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its...
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems New Enhanced Small Particle (ESP™) Detection Option for Cytek Northern Lights™ and Cytek Aurora™ Systems Expands Capabilities of Small Particle Research FREMONT, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Today (Nasdaq: CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship ™ and ™ cell analysis systems. With this optional upgrade, these systems show superior sensitivity and resolution of subcell...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.